Cellyan Biotechnology Co Ltd Cl A

NASDAQ • Healthcare • Medical Distribution • Quote as of 09/22/2026 16:00

Company Profile

IndustryMedical Distribution

SectorHealthcare

ExchangeNASDAQ

Market Capitalization5.6 mln

Float32.37 mln

Earnings Date11/30/2026

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-2.34

Borderline

Relative Strength

20 / 100

Significantly lagging

Debt / Equity

0.13

Very low leverage

Pre-Tax Margin

-8%

Marginally loss-making

ROE

-17.29

Negative

Business Description

Cellyan Biotechnology Co. Ltd, headquartered in Yau Tong, Hong Kong, helps businesses move non-prescription medicines between Hong Kong and Mainland China. Founded in 2023, the company handles procurement, storage, customs processing, and delivery, while also supporting online retail channels. Its clients include online platforms, merchants, and medicine distributors.

Key Fundamentals

EPS-0.07

ROE-17.29

RPS0.57

ROIC-14.55

ROA-10.69

Interest Cover-7.46

EBITDA, mln-0.31

EV / EBITDA-29.80

EV / EBIT-9.23

Revenue, mln13.43

EV / Revenue0.68

Quote Details

Last 0.122

Change 0.0008 (0.66%)

Open 0.1212

Volume 348,135

Turnover 42,472

Average Volume 9,194,179

Financial Ratios

Pre-Tax Profit Margin-8

Leverage Ratio1.34

Current Ratio3.86

Price / Book0.41

Price / Tangible Book0.41

Debt / Equity0.13

Price / Sales0.18

Financial Strength

Altman Z-Score3.3

Piotroski F-Score 3 / 9

Beneish M-Score-2.34

Short Ratio2.19

Short % of Float0.62

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	7.68%	84 / 100
1 Month	-70.15%	0 / 100
2 Months	-72.58%	2 / 100
6 Months	-80.67%	3 / 100
1 Year	-90.83%	4 / 100